Back
Summit Therapeutics Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
70
SMMT
Summit Therapeutics
Last Price:
20.75
Seasonality Move:
32.31%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- The current trend is moderately bullish and SMMT is experiencing slight selling pressure.
Summit Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.39 | Buy |
| 20-day SMA: | 20.72 | Buy |
| 50-day SMA: | 20.73 | Buy |
| 200-day SMA: | 10.05 | Buy |
| 8-day EMA: | 20.89 | Buy |
| 20-day EMA: | 20.61 | Buy |
| 50-day EMA: | 19.33 | Buy |
| 200-day EMA: | 12.08 | Buy |
Summit Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.24 | Buy |
| Relative Strength Index (14 RSI): | 56.09 | Buy |
| Chaikin Money Flow: | -711186 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.16 - 21.68) | Buy |
| Bollinger Bands (100): | (9.24 - 21.52) | Buy |
Summit Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 21.79 while SMMT 8-day simple moving average is 20.39, which is a Buy signal.
- The stock price of SMMT is 21.79 while Summit Therapeutics 20-day SMA is 20.72, which makes it a Buy.
- Summit Therapeutics 50-day simple moving average is 20.73 while SMMT share price is 21.79, making it a Buy technically.
- SMMT stock price is 21.79 and Summit Therapeutics 200-day simple moving average is 10.05, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Buy
70
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a Buy
The current Summit Therapeutics [SMMT] share price is $21.79. The Score for SMMT is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
Summit Therapeutics Stock Info
Market Cap:
16.07B
Price in USD:
21.79
Share Volume:
2.13M
Summit Therapeutics 52-Week Range
52-Week High:
33.89
52-Week Low:
1.79
Buy
70
Summit Therapeutics (SMMT)
is a Buy
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?
The Summit Therapeutics stock price is 21.79 USD today. -
Will SMMT stock go up or go down?
Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Summit Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is not overvalued.
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 21.79 while SMMT 8-day exponential moving average is 20.89, which is a Buy signal.
- The stock price of SMMT is 21.79 while Summit Therapeutics 20-day EMA is 20.61, which makes it a Buy.
- Summit Therapeutics 50-day exponential moving average is 19.33 while SMMT share price is 21.79, making it a Buy technically.
- SMMT stock price is 21.79 and Summit Therapeutics 200-day simple moving average is 12.08, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and a decrease next year of $0.08 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
- SMMT Moving Average Covergence Divergence (MACD) indicator is 0.24, suggesting Summit Therapeutics is a Buy
- Summit Therapeutics Relative Strength Index (RSI) is 56.09, which suggest Summit Therapeutics is overbought
- The Bollinger Bands (25) for Summit Therapeutics is (19.16 - 21.68), which suggest Summit Therapeutics is a Buy
- The Bollinger Bands (100) for Summit Therapeutics is (9.24 - 21.52), which suggest Summit Therapeutics is a Buy
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.